Vitrolife AB

VTFN

Company Profile

  • Business description

    Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient’s fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

  • Contact

    Box 9080
    Gothenburg400 92
    SWE

    T: +46 317218000

    https://www.vitrolife.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,116

Stocks News & Analysis

stocks

Does SpaceX’s sky-high valuation make sense?

SpaceX’s $1.5 trillion valuation looks expensive and risky, but not irrational.
stocks

ASX healthcare leader sees further cuts to fair value

Fiercer competition expected to squeeze margins.
stocks

Avoid this overpriced ASX share

This ASX share is 84% overvalued and lacks a sustainable competitive advantage.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,976.8020.700.23%
CAC 407,968.2025.29-0.32%
DAX 4023,576.94391.69-1.63%
Dow JONES (US)47,706.5134.29-0.07%
FTSE 10010,311.94100.30-0.96%
HKSE25,898.7661.14-0.24%
NASDAQ22,697.101.160.01%
Nikkei 22555,025.37776.981.43%
NZX 50 Index13,293.13198.761.52%
S&P 5006,781.4814.51-0.21%
S&P/ASX 2008,743.5019.400.22%
SSE Composite Index4,133.4310.290.25%

Market Movers